Headlines
-
GHB taking a bigger toll
Tuesday | Feb 3 2026GHB-RELATED deaths have increased 10-fold since 2013, while the number of hospitalisations more than tripled, according to an Australian-first study from the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney.
-
Walk for mental health
Tuesday | Feb 3 2026THE Pedestrian Council of Australia is partnering with the Black Dog Institute this year to lead its annual Walk to Work Day campaign, which has now moved to Fri 27 Mar.
-
IPA gears up for annual conference
Monday | Feb 2 2026INDEPENDENT Pharmacies Australia (IPA) is set to host its second annual Retail Excellence Conference from Sun 08 Feb to Tue 10 Feb 2026 in Melbourne.
-
CPS elects new president
Monday | Feb 2 2026COUNCIL of Pharmacy Schools Australia and New Zealand (CPS) members have elected Associate Professor Ramesh Walpola (pictured) as its new president after Professor Joseph Tucci stood down late in 2025.
-
Counterfeit melatonin warning
Friday | Jan 30 2026CONSUMERS and health professionals are being warned about imported unregistered melatonin products in an updated safety advisory from the Therapeutic Goods Administration (TGA).
-
Daily aspirin does not head off cancer
Friday | Jan 30 2026NEW research has found no effect on overall cancer incidence among healthy older adults who took a low-dose of aspirin daily, but there was an increased risk of cancer-related mortality.
-
My Health Record update welcomed
Thursday | Jan 29 2026HEALTH Minister Mark Butler has proposed major changes to medication record keeping, with the creation of a new National Medicines Record that logs all medicines prescribed and dispensed for patients.
-
Harm prevention services save money, lives
Thursday | Jan 29 2026COMMON harm reduction services such as take-home naloxone, opioid agonist treatment and needle-syringe programs not only reduce negative consequences of drug use, but have economic benefits, according to research led by Burnet Institute and published in the journal Addiction.
-
Therapy aids shift from IV to SC, improves outcomes
Thursday | Jan 29 2026NEW research from Monash Institute of Pharmaceutical Sciences (MIPS) and Halozyme Therapeutics is paving the way for a shift in how anti-cancer immunotherapy is delivered, making it less complex and painful for the patient, and potentially improving the treatment outcome for some medicines.
-
NSW expanded scope training kicks off
Wednesday | Jan 28 2026THE University of Newcastle has commenced the first semester of its expanded scope of practice training program for pharmacists this week, with teaching for the University of Technology Sydney (UTS) program to start mid-Feb.
